IPS Therapeutique (IPST) is a Contract Research Organization (CRO) specializing in the preclinical evaluation of drug efficacy and safety using validated in vivo models. Since 1999, IPST has completed more than 3,000 cardiac studies and over 120 GLP programs supporting submissions to the FDA, EMA and Health Canada.

Operating from a 36,000 sq.ft. facility in Sherbrooke (QC), the team designs customized studies and works closely with clients, with direct involvement from senior scientific leadership.

Our expertise includes: 
- Cardiac models (HFpEF, HFrEF, cardiomyopathies, MI)
- Vascular models (PAH, hemorrhagic shock, preeclampsia)
- Inflammatory and fibrotic models (IPF, NASH, IBD)
- Respiratory models (ARDS, COPD, chronic cough) 
- Coagulation models (thrombosis, thrombocytopenia, anticoagulant reversal)

IPS Therapeutique (IPST)

This office likely oversees research studies and project management in a collaborative environment.

IPS Therapeutique (IPST)

Org chart

Teams

Offices

IPS Therapeutique (IPST)

Org chart

Teams

Offices

Related companies